CN112516262A - Acid-reducing tea for relieving gout and preparation method thereof - Google Patents
Acid-reducing tea for relieving gout and preparation method thereof Download PDFInfo
- Publication number
- CN112516262A CN112516262A CN202011598058.2A CN202011598058A CN112516262A CN 112516262 A CN112516262 A CN 112516262A CN 202011598058 A CN202011598058 A CN 202011598058A CN 112516262 A CN112516262 A CN 112516262A
- Authority
- CN
- China
- Prior art keywords
- parts
- acid
- reducing tea
- relieving gout
- gout
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/24—Mucus; Mucous glands; Bursa; Synovial fluid; Arthral fluid; Excreta; Spinal fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/237—Notopterygium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Polymers & Plastics (AREA)
- Sustainable Development (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Materials Engineering (AREA)
- Neurology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
Abstract
The invention provides a deacidification tea for relieving gout and a preparation method thereof. The acid reducing tea is prepared from the following raw materials, wherein the raw materials comprise 5-10 parts of lily polysaccharide, 1-6 parts of coix seed bud, 1-5 parts of cushaw seed, 1-3 parts of gynostemma pentaphylla, 1-5 parts of ginkgo leaf, 1-4 parts of plantain herb, 0.5-1 part of gentiana macrophylla, 1-2 parts of ligusticum wallichii, 1-5 parts of peach kernel, 1-6 parts of safflower, 1-3 parts of liquorice, 0.5-3 parts of notopterygium root, 0.5-3 parts of angelica, 0.5-4 parts of trogopterus dung, 0.5-2 parts of rhizoma cyperi, 0.5-5 parts of achyranthes root, 0.5-3 parts of earthworm, 0.05-0.2 part of xylo oligosaccharide, 0.02-0.5 part of dipotassium hydrogen phosphate and 0.05-0.2 part of sodium bicarbonate. The acid-reducing tea for relieving gout disclosed by the invention adopts natural traditional Chinese medicinal materials and food materials, and retains bioactive components in the raw materials to the greatest extent through advanced processes such as strict screening, ethanol extraction, vacuum concentration, low-temperature drying and the like, so that the biological active components are reasonably matched, the absorption is effectively promoted, and the health-care effect of relieving gout is achieved; the acid-reducing tea for relieving gout is safe to eat, has no toxic or side effect, regulates qi and blood, promotes blood circulation to remove blood stasis, relieves spasm, dispels wind, promotes diuresis, relieves pain, dispels wind, reduces acidity, promotes discharge of uric acid, and can effectively relieve gout.
Description
Technical Field
The invention belongs to the field of acid-reducing tea, and particularly relates to acid-reducing tea for relieving gout and a preparation method thereof.
Background
Gout is a common and complex type of arthritis, which can be suffered by all ages, with higher incidence in men than women. Patients with gout often have sudden joint pain at night, the joint is in urgent attack, severe pain, edema, red swelling and inflammation appear at the joint, and the pain is slowly relieved until the pain disappears for days or weeks. Hyperuricemia is the basis of gout, and hyperuricemia are over-saturated in urine, so that urate is deposited in the renal tubule lumen or interstitium, and an acute inflammatory reaction is caused. At present, medicines for relieving gout mainly comprise nonsteroidal anti-inflammatory drugs and glucocorticoids, but the existing medicine relieving method is less in use, people prefer to adopt diet therapy, the diet therapy has no side effect, both symptoms and root causes are treated, diet is controlled, foods with rich purine content are strictly limited, and high-purine foods and high-fat foods, such as meat, wild flavor, seafood, yeast-containing foods and beverages, are reduced; eating food with low purine content, such as rice, wheat, starch, sorghum, egg, pig blood, duck blood, etc., as far as possible; at the same time, the health care wine can reduce weight, control weight and properly increase physical activity. In view of this, this patent is filed.
Disclosure of Invention
In order to solve the problems in the prior art, the invention provides an acid-reducing tea for relieving gout and a preparation method thereof. The acid-reducing tea for relieving gout is safe to eat, has no toxic or side effect, has the mutual cooperation of the raw materials, and has a good effect of relieving gout. The invention aims to provide the acid-reducing tea for relieving gout.
The invention also aims to provide two preparation methods of the acid-reducing tea for relieving gout. According to a specific embodiment of the invention, the acid-reducing tea for relieving gout is prepared from the following raw materials, wherein the raw materials comprise 5-10 parts of lily polysaccharide, 1-6 parts of coix sprout, 1-5 parts of cushaw, 1-3 parts of gynostemma pentaphylla, 1-5 parts of ginkgo leaf, 1-4 parts of plantain herb, 0.5-1 part of gentiana macrophylla, 1-2 parts of ligusticum wallichii, 1-5 parts of peach kernel, 1-6 parts of safflower, 1-3 parts of liquorice, 0.5-3 parts of notopterygium root, 0.5-3 parts of angelica sinensis, 0.5-4 parts of trogopterus dung, 0.5-2 parts of rhizoma cyperi, 0.5-5 parts of achyranthes bidentata, 0.5-3 parts of earthworm, 0.05-0.2 parts of xylo oligosaccharide, 0.02-0.5 part of dipotassium hydrogen phosphate and 0.05-0.2 part of sodium bicarbonate. Further, the acid reducing tea is prepared from the following raw materials in parts by weight: 8 parts of lily polysaccharide, 4 parts of coix seed buds, 3 parts of cushaw, 2 parts of gynostemma pentaphylla, 3 parts of ginkgo leaves, 2 parts of plantain, 0.5 part of gentiana macrophylla, 1 part of ligusticum wallichii, 2 parts of peach kernels, 1 part of safflower, 2 parts of liquorice, 1 part of notopterygium roots, 1.5 parts of angelica, 2 parts of trogopterus dung, 1 part of rhizoma cyperi, 2 parts of achyranthes bidentata, 2 parts of earthworms, 0.1 part of xylo-oligosaccharide, 0.2 part of dipotassium hydrogen phosphate and 0.1 part of sodium bicarbonate. Further, the lily polysaccharide is prepared by adopting the following method: crushing and sieving lily, degreasing with ethyl acetate and petroleum ether respectively, adding into distilled water according to the weight ratio of 1:20-30, adjusting pH to 5.0-5.5, and extracting in 85-95 deg.C water bath for 3-5 h; taking the supernatant, cooling, carrying out enzymolysis to remove starch, and then centrifuging to obtain the supernatant; concentrating the supernatant, adding 95% glacial ethanol 2-4 times the volume of the concentrated solution, precipitating overnight to obtain precipitate, and vacuum freeze drying the precipitate to obtain Bulbus Lilii crude polysaccharide; dissolving in water to obtain solution, deproteinizing, decolorizing, dialyzing, and performing ion exchange column chromatography to obtain Bulbus Lilii pure polysaccharide, and vacuum freeze drying to obtain Bulbus Lilii polysaccharide. Further, the coix seed bud is prepared by adopting the following method: soaking Coicis semen in 25-35 deg.C water for 20-25 hr, and germinating at room temperature for 2-3 days; cleaning germinated Coicis semen and root, oven drying at 45-55 deg.C, and pulverizing to obtain Coicis semen bud powder; adding equal weight of water, adding 2-4% of saccharifying enzyme, filtering, collecting filtrate, concentrating, and spray drying to obtain Coicis semen bud.
Further, the preparation method of the acid-reducing tea for relieving gout comprises the following steps: weighing lily polysaccharide and coix seed buds according to a proportion, mixing, and uniformly mixing to form a mixed fine material; (2) crushing the other raw materials except the lily polysaccharide and the coix seed buds respectively, then mixing, uniformly mixing to form a material to be extracted, soaking the material to be extracted by using 60-90% ethanol as a solvent for 6-18 hours, filtering, collecting filtrate, recovering ethanol, and concentrating into paste to form paste; and (3) drying the paste obtained in the step (2) in vacuum, crushing, mixing with the mixed fine powder obtained in the step (1), uniformly mixing, and sieving to obtain the deacidification tea for relieving gout.
Further, in the step (2), the crushing is carried out by adopting a wall breaking machine. Further, in the step (2), the fineness of the crushed particles is 100 meshes. Further, in the step (3), the sieving is 400-mesh sieving.
Further, sterilizing the acid reducing tea for relieving gout, granulating into granules or powder by adopting a granulator, weighing and packaging to form the tea bag.
The dosage form of the acid-reducing tea for relieving gout is liquid preparation, granules, powder and tablets.
The invention has the beneficial effects that:
1. the acid-reducing tea for relieving gout disclosed by the invention adopts natural traditional Chinese medicinal materials and food materials, and retains bioactive components in the raw materials to the greatest extent through advanced processes such as strict screening, ethanol extraction, vacuum concentration, low-temperature drying and the like, so that the biological active components are reasonably matched, the absorption is effectively promoted, and the health-care effect of relieving gout is achieved;
2. the acid-reducing tea for relieving gout is safe to eat, has no toxic or side effect, regulates qi and blood, promotes blood circulation to remove blood stasis, relieves spasm, dispels wind, promotes diuresis, relieves pain, dispels wind, reduces acid, promotes discharge of uric acid, and can effectively relieve gout;
3. the preparation method of the acid-reducing tea for relieving gout is simple and easy to operate, has strong reproducibility and is beneficial to large-scale production.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the technical solutions of the present invention will be described in detail below. It is to be understood that the described embodiments are merely exemplary of the invention, and not restrictive of the full scope of the invention. All other embodiments, which can be derived by a person skilled in the art from the examples given herein without any inventive step, are within the scope of the present invention.
Example 1
The embodiment provides an acid-reducing tea for relieving gout, which is prepared from the following raw materials: the raw materials comprise 5 parts of lily polysaccharide, 1 part of coix sprout, 1 part of cushaw, 1 part of gynostemma pentaphylla, 1 part of ginkgo leaf, 1 part of plantain herb, 0.5 part of large-leaved gentian, 1 part of szechuan lovage rhizome, 1 part of peach kernel, 1 part of safflower, 1 part of liquorice, 0.5 part of notopterygium root, 0.5 part of Chinese angelica, 0.5 part of trogopterus dung, 0.5 part of nutgrass galingale rhizome, 0.5 part of twotooth achyranthes root, 0.5 part of earthworm, 0.05 part of xylo-oligosaccharide, 0.02 part of dipotassium hydrogen phosphate and 0.05 part of sodium bicarbonate. The lily polysaccharide is prepared by the following method: crushing and sieving lily, degreasing with ethyl acetate and petroleum ether respectively, adding into distilled water according to the weight ratio of 1:20-30, adjusting pH to 5.0-5.5, and extracting in 85-95 deg.C water bath for 3-5 h; taking the supernatant, cooling, carrying out enzymolysis to remove starch, and then centrifuging to obtain the supernatant; concentrating the supernatant, adding 95% glacial ethanol 2-4 times the volume of the concentrated solution, precipitating overnight to obtain precipitate, and vacuum freeze drying the precipitate to obtain Bulbus Lilii crude polysaccharide; dissolving in water to obtain solution, deproteinizing, decolorizing, dialyzing, and performing ion exchange column chromatography to obtain Bulbus Lilii pure polysaccharide, and vacuum freeze drying to obtain Bulbus Lilii polysaccharide. The coix seed bud is prepared by the following method: soaking Coicis semen in 25-35 deg.C water for 20-25 hr, and germinating at room temperature for 2-3 days; cleaning germinated Coicis semen and root, oven drying at 45-55 deg.C, and pulverizing to obtain Coicis semen bud powder; adding equal weight of water, adding 2-4% of saccharifying enzyme, filtering, collecting filtrate, concentrating, and spray drying to obtain Coicis semen bud. The preparation method of the acid-reducing tea for relieving gout comprises the following steps: weighing lily polysaccharide and coix seed buds according to a proportion, mixing, and uniformly mixing to form a mixed fine material; (2) crushing the other raw materials except the lily polysaccharide and the coix seed buds respectively, then mixing, uniformly mixing to form a material to be extracted, soaking the material to be extracted by using 60-90% ethanol as a solvent for 6-18 hours, filtering, collecting filtrate, recovering ethanol, and concentrating into paste to form paste; and (3) drying the paste obtained in the step (2) in vacuum, crushing, mixing with the mixed fine powder obtained in the step (1), uniformly mixing, and sieving to obtain the deacidification tea for relieving gout. In the step (2), the crushing is carried out by adopting a wall breaking machine, and the sieving is carried out by sieving with a 400-mesh sieve. Sterilizing the acid reducing tea for relieving gout, granulating into granules or powder by adopting a granulator, weighing and packaging to form the tea bag.
Example 2
The embodiment provides an acid-reducing tea for relieving gout, which is prepared from the following raw materials: 8 parts of lily polysaccharide, 4 parts of coix seed buds, 3 parts of cushaw, 2 parts of gynostemma pentaphylla, 3 parts of ginkgo leaves, 2 parts of plantain, 0.5 part of gentiana macrophylla, 1 part of ligusticum wallichii, 2 parts of peach kernels, 1 part of safflower, 2 parts of liquorice, 1 part of notopterygium roots, 1.5 parts of angelica, 2 parts of trogopterus dung, 1 part of rhizoma cyperi, 2 parts of achyranthes bidentata, 2 parts of earthworms, 0.1 part of xylo-oligosaccharide, 0.2 part of dipotassium hydrogen phosphate and 0.1 part of sodium bicarbonate. The lily polysaccharide is prepared by the following method: crushing and sieving lily, degreasing with ethyl acetate and petroleum ether respectively, adding into distilled water according to the weight ratio of 1:20-30, adjusting pH to 5.0-5.5, and extracting in 85-95 deg.C water bath for 3-5 h; taking the supernatant, cooling, carrying out enzymolysis to remove starch, and then centrifuging to obtain the supernatant; concentrating the supernatant, adding 95% glacial ethanol 2-4 times the volume of the concentrated solution, precipitating overnight to obtain precipitate, and vacuum freeze drying the precipitate to obtain Bulbus Lilii crude polysaccharide; dissolving in water to obtain solution, deproteinizing, decolorizing, dialyzing, and performing ion exchange column chromatography to obtain Bulbus Lilii pure polysaccharide, and vacuum freeze drying to obtain Bulbus Lilii polysaccharide. The coix seed bud is prepared by the following method: soaking Coicis semen in 25-35 deg.C water for 20-25 hr, and germinating at room temperature for 2-3 days; cleaning germinated Coicis semen and root, oven drying at 45-55 deg.C, and pulverizing to obtain Coicis semen bud powder; adding equal weight of water, adding 2-4% of saccharifying enzyme, filtering, collecting filtrate, concentrating, and spray drying to obtain Coicis semen bud. The preparation method of the acid-reducing tea for relieving gout comprises the following steps: weighing lily polysaccharide and coix seed buds according to a proportion, mixing, and uniformly mixing to form a mixed fine material; (2) crushing the other raw materials except the lily polysaccharide and the coix seed buds respectively, then mixing, uniformly mixing to form a material to be extracted, soaking the material to be extracted by using 60-90% ethanol as a solvent for 6-18 hours, filtering, collecting filtrate, recovering ethanol, and concentrating into paste to form paste; and (3) drying the paste obtained in the step (2) in vacuum, crushing, mixing with the mixed fine powder obtained in the step (1), uniformly mixing, and sieving to obtain the deacidification tea for relieving gout. In the step (2), the crushing is carried out by adopting a wall breaking machine, and the sieving is carried out by sieving with a 400-mesh sieve. Sterilizing the acid reducing tea for relieving gout, granulating into granules or powder by adopting a granulator, weighing and packaging to form the tea bag.
Example 3
The embodiment provides an acid-reducing tea for relieving gout, which is prepared from the following raw materials: the raw materials comprise 10 parts of lily polysaccharide, 6 parts of coix seed buds, 5 parts of pumpkin seeds, 3 parts of gynostemma pentaphylla, 5 parts of ginkgo leaves, 4 parts of plantain herbs, 1 part of large-leaved gentian, 2 parts of ligusticum wallichii, 5 parts of peach kernels, 6 parts of safflower, 3 parts of liquorice, 3 parts of notopterygium roots, 3 parts of angelica sinensis, 4 parts of trogopterus dung, 2 parts of rhizoma cyperi, 5 parts of achyranthes roots, 3 parts of earthworms, 0.2 part of xylo-oligosaccharide, 0.5 part of dipotassium hydrogen phosphate and 0.2 part of sodium bicarbonate. The lily polysaccharide is prepared by the following method: crushing and sieving lily, degreasing with ethyl acetate and petroleum ether respectively, adding into distilled water according to the weight ratio of 1:20-30, adjusting pH to 5.0-5.5, and extracting in 85-95 deg.C water bath for 3-5 h; taking the supernatant, cooling, carrying out enzymolysis to remove starch, and then centrifuging to obtain the supernatant; concentrating the supernatant, adding 95% glacial ethanol 2-4 times the volume of the concentrated solution, precipitating overnight to obtain precipitate, and vacuum freeze drying the precipitate to obtain Bulbus Lilii crude polysaccharide; dissolving in water to obtain solution, deproteinizing, decolorizing, dialyzing, and performing ion exchange column chromatography to obtain Bulbus Lilii pure polysaccharide, and vacuum freeze drying to obtain Bulbus Lilii polysaccharide.
The coix seed bud is prepared by the following method: soaking Coicis semen in 25-35 deg.C water for 20-25 hr, and germinating at room temperature for 2-3 days; cleaning germinated Coicis semen and root, oven drying at 45-55 deg.C, and pulverizing to obtain Coicis semen bud powder; adding equal weight of water, adding 2-4% of saccharifying enzyme, filtering, collecting filtrate, concentrating, and spray drying to obtain Coicis semen bud.
The preparation method of the acid-reducing tea for relieving gout comprises the following steps: weighing lily polysaccharide and coix seed buds according to a proportion, mixing, and uniformly mixing to form a mixed fine material; (2) crushing the other raw materials except the lily polysaccharide and the coix seed buds respectively, then mixing, uniformly mixing to form a material to be extracted, soaking the material to be extracted by using 60-90% ethanol as a solvent for 6-18 hours, filtering, collecting filtrate, recovering ethanol, and concentrating into paste to form paste; and (3) drying the paste obtained in the step (2) in vacuum, crushing, mixing with the mixed fine powder obtained in the step (1), uniformly mixing, and sieving to obtain the deacidification tea for relieving gout. In the step (2), the crushing is carried out by adopting a wall breaking machine, and in the step (3), the sieving is carried out by sieving with a 400-mesh sieve. Sterilizing the acid reducing tea for relieving gout, granulating into granules or powder by adopting a granulator, weighing and packaging to form the tea bag.
The acid-reducing tea for relieving gout is not suitable for children.
Note that: it can not replace the drugs. The prepared deacidification tea for relieving gout is subjected to hygiene and stability detection:
1. sample preparation: the samples are powder, and 0.9g of the powdery anti-acid tea for relieving gout, which is obtained in examples 1 to 3 of the invention, is taken as 3 samples and stored at normal temperature.
2. The inspection basis is as follows: GB/T5009 food hygiene physicochemical inspection method, pharmacopeia 2000 edition, GB4789-1994 food hygiene microorganism inspection method, health department internal standard method, etc. 3. And (4) testing results: (1) hygiene examination: the sample is tested according to the method specified in the national standard, and the result shows that the relevant indexes of the sample hygiene conform to the national standard. (2) stability test: a part of samples are subjected to a three-month heat preservation experiment at the temperature of 38 +/-1 ℃ and the relative humidity of 75 percent, and physicochemical and microbial detection shows that the quality of detected indexes is stable.
3. Clinical data: the medicine is prepared from 81 male and female, 78 male and 3 female, wherein the age is 24-83 years, the average age is 43.47 years, the course of the disease is 1 month-21 years, the average age is 1.12 years, the blood uric acid is 361.7-897.7 mu mol/L and the average age is 563.5 mu mol/L, and the medicine is combined with 9 cases of hypertension, 9 cases of hyperlipidemia, 2 cases of diabetes, 4 cases of renal insufficiency and 3 cases of renal calculus. Diagnostic criteria: the diagnostic criteria for gout, which were established in 1997 by the American rheumatism Association, were adopted. 1, the acute arthritis attacks more than once, and the peak of the attack is reached within 1 day; ② acute arthritis is limited to individual joints; the whole joint is dark red; fourthly, swelling and pain of the first toe joint; acute attack of unilateral toe arthritis; sixthly, tophus exists; seventhly, hyperuricemia; eighty asymmetric joint gall; and ninthly, the attack can be automatically stopped. The patients with more than 3 items except secondary gout can be diagnosed. 2. The mitigation scheme comprises the following steps: the powder obtained in example 2 is dissolved in about 200mL of boiled water and is taken orally for 2 times, which is inconvenient for people taking the powder for 2 times to take the powder for 1 time. 2 weeks is a course of treatment, and 6 courses of treatment are relieved. 3. The curative effect is as follows: the joint red swelling and hot pain disappear, the local part is normal, the joint moves freely, and the blood uric acid is reduced to normal. Improvement: the joint swelling is reduced, the pain is stopped, the attack is obviously reduced, the normal activity can be realized, the blood uric acid is reduced but not in the normal range, and the medicine is occasionally taken. The disease is not cured: the joint swelling and pain are not improved, and the blood uric acid is not obviously changed or even increased.
4. The mitigation results are: 53 cases (65.43%) with obvious effect, 28 cases (34.57%) with effective effect, 0 case without cure and 100% total effective rate.
The above description is only for the specific embodiments of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art can easily conceive of the changes or substitutions within the technical scope of the present invention, and all the changes or substitutions should be covered within the scope of the present invention. Therefore, the protection scope of the present invention shall be subject to the protection scope of the appended claims.
Claims (9)
1. The acid-reducing tea for relieving gout is prepared from the following raw materials: 5-10 parts of lily polysaccharide, 1-6 parts of coix seed buds, 1-5 parts of cushaw, 1-3 parts of gynostemma pentaphylla, 1-5 parts of ginkgo leaves, 1-4 parts of plantain herb, 0.5-1 part of gentiana macrophylla, 1-2 parts of ligusticum wallichii, 1-5 parts of peach kernels, 1-6 parts of safflower carthamus, 1-3 parts of liquorice, 0.5-3 parts of notopterygium root, 0.5-3 parts of angelica sinensis, 0.5-4 parts of trogopterus dung, 0.5-2 parts of rhizoma cyperi, 0.5-5 parts of achyranthes bidentata, 0.5-3 parts of earthworm, 0.05-0.2 part of xylo-oligosaccharide, 0.02-0.5 part of dipotassium hydrogen phosphate and 0.05-0.2 part of sodium bicarbonate.
2. The acid-reducing tea for relieving gout as claimed in claim 1, wherein the acid-reducing tea is prepared from the following raw materials in parts by weight: 8 parts of lily polysaccharide, 4 parts of coix seed buds, 3 parts of cushaw, 2 parts of gynostemma pentaphylla, 3 parts of ginkgo leaves, 2 parts of plantain, 0.5 part of gentiana macrophylla, 1 part of ligusticum wallichii, 2 parts of peach kernels, 1 part of safflower, 2 parts of liquorice, 1 part of notopterygium roots, 1.5 parts of angelica, 2 parts of trogopterus dung, 1 part of rhizoma cyperi, 2 parts of achyranthes bidentata, 2 parts of earthworms, 0.1 part of xylo-oligosaccharide, 0.2 part of dipotassium hydrogen phosphate and 0.1 part of sodium bicarbonate.
3. The acid-reducing tea for relieving gout as claimed in claims 1-2, wherein the lily polysaccharide is prepared by the following method: crushing and sieving lily, degreasing with ethyl acetate and petroleum ether respectively, adding into distilled water according to the weight ratio of 1:20-30, adjusting pH to 5.0-5.5, and extracting in 85-95 deg.C water bath for 3-5 h; taking the supernatant, cooling, carrying out enzymolysis to remove starch, and then centrifuging to obtain the supernatant; concentrating the supernatant, adding 95% glacial ethanol 2-4 times the volume of the concentrated solution, precipitating overnight to obtain precipitate, and vacuum freeze drying the precipitate to obtain Bulbus Lilii crude polysaccharide; dissolving in water to obtain solution, deproteinizing, decolorizing, dialyzing, and performing ion exchange column chromatography to obtain Bulbus Lilii pure polysaccharide, and vacuum freeze drying to obtain Bulbus Lilii polysaccharide.
4. The acid-reducing tea for relieving gout as claimed in claims 1-2, wherein the coix seed buds are prepared by the following method: soaking Coicis semen in 25-35 deg.C water for 20-25 hr, and germinating at room temperature for 2-3 days; cleaning germinated Coicis semen and root, oven drying at 45-55 deg.C, and pulverizing to obtain Coicis semen bud powder; adding equal weight of water, adding 2-4% of saccharifying enzyme, filtering, collecting filtrate, concentrating, and spray drying to obtain Coicis semen bud.
5. The preparation method of the acid-reducing tea for relieving gout as claimed in any one of claims 1 to 4, which comprises the following steps: weighing lily polysaccharide and coix seed buds according to a proportion, mixing, and uniformly mixing to form a mixed fine material; (2) crushing the other raw materials except the lily polysaccharide and the coix seed buds respectively, then mixing, uniformly mixing to form a material to be extracted, soaking the material to be extracted by using 60-90% ethanol as a solvent for 6-18 hours, filtering, collecting filtrate, recovering ethanol, and concentrating into paste to form paste; and (3) drying the paste obtained in the step (2) in vacuum, crushing, mixing with the mixed fine powder obtained in the step (1), uniformly mixing, and sieving to obtain the deacidification tea for relieving gout.
6. The preparation method of the acid-reducing tea for relieving gout as claimed in claim 5, wherein in the step (2), the crushing is carried out by a wall breaking machine.
7. The preparation method of the acid-reducing tea for relieving gout as claimed in claim 5, wherein in the step (2), the particle fineness after the crushing is 100 meshes.
8. The preparation method of the acid-reducing tea for relieving gout as claimed in claim 5, wherein in the step (3), the sieving is performed by a 400-mesh sieve.
9. The acid-reducing tea for relieving gout as claimed in claims 1 to 8, wherein the dosage form is liquid preparation, granules, powder and tablets.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011598058.2A CN112516262A (en) | 2020-12-29 | 2020-12-29 | Acid-reducing tea for relieving gout and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011598058.2A CN112516262A (en) | 2020-12-29 | 2020-12-29 | Acid-reducing tea for relieving gout and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112516262A true CN112516262A (en) | 2021-03-19 |
Family
ID=74977362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011598058.2A Pending CN112516262A (en) | 2020-12-29 | 2020-12-29 | Acid-reducing tea for relieving gout and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112516262A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113288979A (en) * | 2021-05-26 | 2021-08-24 | 青鼎木（武汉）生物科技有限公司 | Composition for reducing uric acid and relieving gout |
-
2020
- 2020-12-29 CN CN202011598058.2A patent/CN112516262A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113288979A (en) * | 2021-05-26 | 2021-08-24 | 青鼎木（武汉）生物科技有限公司 | Composition for reducing uric acid and relieving gout |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111617231B (en) | Uric acid-reducing and gout-resisting composition as well as preparation method and application thereof | |
| CN103652360B (en) | Feed for curing pig paratyphus and preparation method thereof | |
| CN103622019A (en) | Traditional Chinese medicine composition capable of reducing blood lipid and uric acid | |
| CN101695327B (en) | Health-care kidney tea | |
| CN113499393A (en) | Composition with gastric mucosa injury protection effect and preparation method thereof | |
| CN104758404B (en) | A kind of three snake compound powder of compound and preparation method thereof | |
| CN108714194A (en) | A kind of natural composition prevented or treat hyperuricemia and gout | |
| CN110755542A (en) | Formula of uric acid-reducing gout-treating tea and preparation method thereof | |
| CN104922173A (en) | Application of radix acanthopanacis trifoliate extract in inhibiting alpha-glucosidase | |
| CN108210547B (en) | Preparation method of phyllanthus emblica leaf extract, preparation and anti-artemisia application thereof | |
| CN112516262A (en) | Acid-reducing tea for relieving gout and preparation method thereof | |
| CN110840930A (en) | Method for extracting xanthine oxidase inhibitor from perilla leaves with assistance of ultrasonic waves | |
| CN101152223B (en) | Use of poplar leaf phenols extract in preparation of medicine for treating cardiovascular disease | |
| CN107456495A (en) | It is a kind of be used to coughing, abundant expectoration, the composition granule and preparation method thereof of asthma | |
| CN113875864A (en) | Blood sugar reducing and inhibiting tea and preparation method thereof | |
| CN106039035A (en) | Traditional Chinese medicine composition for fully boosting immunity of human body | |
| CN110787273A (en) | Traditional Chinese medicine composition for regulating uric acid and application thereof | |
| CN103656355B (en) | Medicine being used for the treatment of swine paratyphoid and preparation method thereof | |
| CN109528857A (en) | A kind of campanulaceae particle and preparation method thereof for treating respiratory disease caused by haze | |
| CN106138494B (en) | Kidney nourishing composition and production method thereof | |
| CN113288979A (en) | Composition for reducing uric acid and relieving gout | |
| CN112472758A (en) | Acid-reducing tea for relieving gout and preparation method thereof | |
| CN103599419B (en) | Traditional Chinese medicine combination for treating gout | |
| CN114869930B (en) | Silver bar powder for traditional Chinese medicine composition and preparation process and application thereof | |
| CN109718320B (en) | Functional beverage for reducing uric acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication |